CHELMSFORD, Mass., March 28, 2018 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) announced today that it has executed a definitive agreement to acquire Tec-Sem Group AG, a provider of semiconductor fab automation equipment with a focus on reticle management. Tec-Sem is headquartered in Tӓgerwilen, Switzerland with a sales and service team supporting customers worldwide. The total cash purchase price of the acquisition will be approximately $16 million, subject to customary working capital and other adjustments. The acquisition is expected to close in early April upon satisfaction of customary closing conditions.
Tec-Sem has been selling and supporting innovative automation solutions for the semiconductor industry for more than 30 years. Tec-Sem is a leading provider of reticle management solutions, with a bare reticle stocker system that can store up to 2,880 reticles and provide inspection and pod transfer capabilities. The company's reticle stockers are used by leading chip manufacturers worldwide for contaminant-free storage of reticles, which are the masks that contain the patterns that are ultimately transferred to the wafer surface.
"Tec-Sem is a great fit for our contamination control solutions," commented Dave Jarzynka, Senior Vice President and General Manager of Brooks Semiconductor Solutions Group. "Most of Tec-Sem's revenue is derived from large IC manufacturers, further strengthening our relationships with this important customer base."
Tec-Sem generated approximately $14 million of revenue in the calendar year ended December 31, 2017. Management expects the acquisition will become accretive to Brooks' non-GAAP earnings within the current fiscal year. At the anticipated April closing Brooks will acquire approximately 93% of Tec-Sem's outstanding capital stock. The remaining minority interest will be acquired in due course upon completion of subsequent procedural steps.
About Brooks Automation, Inc.
Brooks is a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences. Brooks' technologies, engineering competencies and global service capabilities provide customers speed to market and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market. Since 2011, Brooks has applied its automation and cryogenics expertise to meet the sample storage needs of customers in the life sciences industry. Brooks' life sciences offerings include a broad range of products and services for on-site infrastructure for sample management in temperatures of ‑20°C to -150°C, as well as comprehensive outsource service solutions across the complete life cycle of biological samples including collection, transportation, processing, storage, protection, retrieval and disposal. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe and Asia. For more information, visit www.brooks.com.
"Safe Harbor Statement" under Section 21E of the Securities Exchange Act of 1934
Some statements in this release are forward-looking statements made under Section 21E of the Securities Exchange Act of 1934. These statements are neither promises nor guarantees but involve risks and uncertainties, both known and unknown, that could cause Brooks' financial and business results to differ materially from our expectations. They are based on the facts known to management at the time they are made. These forward-looking statements include, but are not limited to statements about the anticipated benefits of the acquisition of Tec Sem and the expected future capabilities of the combined companies. Factors that could cause results to differ from our expectations include the following: potential difficulties with the integration of the Tec Sem business into Brooks Life Science Systems and potential adverse reactions or changes to business relationships resulting from Brooks' ownership of the Tec Sem business. In addition, actual results are subject to other risks that relate more broadly to Brooks' overall business, including those that we have described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K, current reports on Form 8-K and our quarterly reports on Form 10-Q. As a result we can provide no assurance that our future results will not be materially different from those projected. Brooks expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based. Brooks undertakes no obligation to update the information contained in this press release.
Senior Managing Director